Cargando…
(18) F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis– Frontotemporal Spectrum Disorder (ALS-FTSD)
Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disorder involving both upper and lower motor neurons. Interestingly, 15 to 41% of patients with ALS have concomitant frontotemporal dementia (FTD). Approximately, 50% of patients with ALS can copresent with a broader s...
Autores principales: | Mashriqi, Faizullah, Mishra, Bibhuti B., Giliberto, Luca, Franceschi, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202568/ https://www.ncbi.nlm.nih.gov/pubmed/37223625 http://dx.doi.org/10.1055/s-0043-1760762 |
Ejemplares similares
-
Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis—Frontotemporal Spectrum Disorder (ALS-FTSD). A Review
por: Moszczynski, Alexander J., et al.
Publicado: (2018) -
The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum
por: van Langenhove, Tim, et al.
Publicado: (2012) -
The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis—Frontotemporal Dementia
por: Scarian, Eveljn, et al.
Publicado: (2022) -
Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
por: Bergh, Sofia, et al.
Publicado: (2022) -
Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum
por: Tse, Nga Yan, et al.
Publicado: (2022)